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SUMMARY
Background: Various organs including heart, kidneys, liver or brain respond to brief exposures to ischemia with
an increased resistance to severe ischemia and this phenomenon is called ÔpreconditioningÕ. No study so for has
been undertaken to check whether such short, repeated gastric ischemic episodes protect gastric mucosa against
the damage caused by subsequent prolonged ischemia-reperfusion or necrotizing substances.
Material and Methods: In this study, cyclooxygenase (COX)-1, COX-2, nitric oxide (NO) and adenosine receptors inhibi-
tors were used to determine the possible involvement of endogenous prostaglandin, NO and adenosine in the mechanism
of gastric preconditioning. This ischemic preconditioning was induced by short episodes of occlusion of celiac artery from 1
to 5 times, for 5 min each applied 30 min before prolonged (30 min) ischemia followed by 3 h of reperfusion (I/R) or 30
min before topical application of strong mucosal irritants such as 100% ethanol, 25% NaCl or 80 mM taurocholate.
Results: Exposure to regular I/R produced numerous gastric lesions and significant fall in the gastric blood flow and
PGE2 generation. Short (5 min) ischemic episodes even induced several times (1-5 times) by itself failed to cause any
gastric lesions but significantly attenuated those produced by I/R and this protective effect reached maximum with
two 5 min ischemic episodes and this preconditioning was considered as standard. The protective effects of standard
ischemic preconditioning against gastric lesions induced by I/R was accompanied by a reversal of the fall in the ga-
stric blood flow and PGE2 generation and resembled those induced by classic gastric mild irritants such as 20%
ethanol, 5% NaCl and 5 mM taurocholate. These protective and hyperemic effects of standard preconditioning, la-
sted up to 6-8 h, and were significantly attenuated by pretreatment with specific COX-1 and COX-2 inhibitors such
as Vioxx (5 mg/kg i.g.) and resveratrol (10 mg/kg i.g.) that failed to affect PGE2 generation in intact gastric mucosa
but attenuated significantly that in preconditioned gastric mucosa. Non-specific COX-inhibitor indomethacin (5
mg/kg i.p.), that suppressed the PGE2 generation by ~90% and non-specific NO synthase inhibitor L-NNA (20
mg/kg i. p.), that significantly suppressed NO production, significantly inhibited the protection and the rise in GBF in-
duced by standard preconditioning and these effects were restored by addition of 16,16 dm PGE2 (1 µg/kg i.g.) or L-
-arginine (200 mg/kg i.g.), a substrate for NO-synthase, to indomethacin or L-NAME, respectively. Pretreatment with
adenosine (10 mg/kg i.g.) also reduced the lesions induced by I/R and increased the gastric blood flow with the extent
similar to that observed with standard ischemic preconditioning, while an antagonist of adenosine receptors, 8-phenyl
theophylline (SPT, 10 mg/kg i.g.) attenuated significantly the gastroprotection afforded by the preconditioning. Gene
expression of COX-1 but not COX-2 was detected by RT-PCR in intact gastric mucosa and in that exposed to
I/R with or without ischemic preconditioning, whereas COX-2 was overexpressed only in preconditioned mucosa. 
Conclusions: 1) gastric ischemic preconditioning represents one of the most powerful protective intervention aga-
inst the mucosal damage induced by severe I/R as well as by topical mucosal irritants in the stomach; 2) this pro-
tection, involving several mediators such as PG derived from COX-1 and COX-2, NO originating from NO-syn-
thase and adenosine, appear to play a key mechanism of gastric ischemic preconditioning.
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BACKGROUND
Ischemia preconditioning refers to a phenomenon
in which a tissue is rendered resistant to the delete-
rious effect of prolonged severe ischemia by pre-
vious exposures to brief vascular occlusions [1].
This protective effect of ischemic preconditioning
were first described in the heart by Murry and co-
workers [2]. Since that time, ischemic preconditio-
ning has been shown to reduce the extent of my-
ocardial infarct size as well as the damage to the
brain, liver, kidneys and skeletal muscle induced
by subsequent exposure to severe ischemia in a va-
riety of species [3—6], but the mechanism of this or-
gan protection by such ischemic preconditioning
has not been fully clarified.
The protective activity of ischemic preconditioning
is best documented phenomenon in the heart
where repeated short episodes of coronary occlu-
sion were shown to prevent lethal injury of the my-
ocardium induced by subsequent long-term and
severe I/R [7,8]. In another report, ischemic pre-
conditioning of rat mesenteric venules led to en-
hanced bioavailability of nitric oxide (NO) and
abolished oxidant production resulting in the de-
crease in the leukocyte adhesion and emigration
through mesentery [9,10]. This indicates that ische-
mic preconditioning also exists in the gut, possibly
preventing the mesenteric microvascular barrier
dysfunction and activation of excessive amount of
NO in the intestine [9—11].
The mechanism of ischemic preconditioning rema-
ins unclear but adenosine that is produced during
the ischemic preconditioning was proposed to act
as an initiator of this preconditioning in different
organs, because of beneficial effect of adenosine in
attenuating the injury caused by severe I/R and an
evidence that protective effects of ischemic pre-
conditioning can be reversed by adenosine recep-
tor antagonists [6,12].
The question remains whether similar protective
effect of ischemic preconditioning can also be ob-
served in the gastric mucosa subjected to longer
I/R or to strong mucosal irritants and if so which
mechanism is involved in this preconditioning re-
sponse. Similar protective effects so called adapti-
ve cytoprotection, were originally revealed in the
stomach by Robert et al, [13] and confirmed by
our group [14] more than two decades ago by
showing the protective action of certain mild irri-
tants such as 20% ethanol, 5% NaCl or 5 mM tau-
rocholate against the damage induced by these
agents applied intragastrically in large mucosal
necrotizing concentrations. This action of mild ir-
ritants has been predominantly attributed to the
protective effects of endogenous prostaglandin
but then besides prostaglandin many other pro-
tective factors such as nonprotein sulfhydryl com-
pounds NO, sensory nerves, calcitonin gene rela-
ted peptide (CGRP) and have been implicated in
this phenomenon [15—18]. The oldest mediator of
gastroprotection, prostaglandin were found to ori-
ginate from at least two cyclooxygenases (COX),
one constitutive (cyclooxygenase-1) playing role
in physiological of mucosal homeostasis and ano-
ther, inducible (cyclooxygenase-2) isoform that is
expressed at a site of inflammation [19,20], but
the contribution of either isoform of cyclooxyge-
nases in gastric preconditioning has not been
explored.
This study was designed to determine whether
ischemic preconditioning exists in the stomach and
if so to elucidate the contribution of endogenous
prostaglandins and NO to gastroprotection against
I/R induced by standard ischemic preconditioning.
We also attempted to explore the involvement of
adenosine in the mechanism of ischemic precondi-
tioning and to assess the mucosal gene and protein
expression of COX-1 and COX-2 in gastric mucosa
subjected to ischemic preconditioning with or wi-
thout prolonged I/R.
MATERIAL AND METHODS
Male Wistar rats weighing 180—220 g were used in
all studies. Rats were fasted 18 h before the experi-
ment but they had free access to the drinking water.
Production of gastric lesions induced 
by ischemia-reperfusion
I/R-induced erosions were produced in 120 rats by
the method originally proposed by Wada et al [21].
Briefly, under pentobarbital anesthesia (50 mg/kg
i.p.), the abdomen was opened, the celiac artery
identified and clamped with a small device for 30
min followed by removal of the clamp to obtain re-
perfusion. In addition, short ischemia (occlusion of
celiac artery 1—5 times for 5 min-ischemic precon-
ditioning) was applied 30 min before subsequent
exposure to longer (regular) 30 min of ischemia (al-
so induced by clamping of celiac artery) and follo-
wed by 3 h of reperfusion. The respective control
group included the sham-operated control animals,
whose the celiac artery was only slightly manipula-
ted but not occluded. First, we attempted to deter-
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mine the effect of various time periods of gastric
ischemic preconditioning on the lesions induced
by regular I/R. For this purpose, rats were precon-
ditioned with single episode of gastric preconditio-
ning ranging from 37 up to 300 s before the expo-
sure to 30 min of ischemia followed by 3 h of re-
perfusion. Second, we wanted to know whether
the increasing number of short ischemic episodes
affects the lesions induced by I/R. For this purpose
gastric mucosa was pretreated with 1 to 5 episodes
of short ischemia (5 min each) before the exposure
to regular I/R. In another group of rats, the dura-
tion of protective effect of standard ischemic pre-
conditioning (2 ´ 5 min occlusion) against the ga-
stric erosions caused by regular I/R was studied.
The duration of the preconditioning effect was exa-
mined in rats pretreated with standard (2 ´ 5 min
occlusion) ischemic preconditioning followed 1h,
2h, 4h, 8h or 12 h later by regular I/R.
Effect of suppression of COX-1 and COX-2 activity
on gastric ischemic preconditioning
In separate group of rats, the pretreatment with
COX inhibitors was employed 30 min prior to ga-
stric preconditioning followed by 3 h of I/R in order
to determine whether suppression of non-selective
or selective inhibitors of COX-1 and COX-2 influen-
ces the protective action of the preconditioning.
Several groups of rats, each consisting of 6-8 ani-
mals, were given 30 min before gastric precondi-
tioning one of the following treatments: 1) vehicle
(saline), 2) resveratrol (1,3-Benzenediol,5-[2-(4-hy-
droxyphenyl) ethenyl], 10 mg/kg i.g.), a selective
COX-1 inhibitor [22]; 3) Vioxx (5 mg/kg i.g), the hi-
ghly selective COX-2 inhibitor [23]; and 4) indo-
methacin (5 mg/kg i.p.), a non-selective cyclooxy-
genase inhibitor [24]. At the dose used in present
study, indomethacin has been shown previously to
inhibit gastric prostaglandin E2 generation capabili-
ty by ~ 90 % without causing by itself any mucosal
damage [25]. The dose of Vioxx was selected on
the basis of previous studies showing that this agent
failed to affect the generation of prostaglandin E2
(PGE2) in intact gastric mucosa but inhibited signifi-
cantly the gastric PGE2 production in ulcerated ga-
stric mucosa [23]. Resveratrol (Cayman Chemical
Co, Ann Arbor, Michigan, USA) was first dissolved
in absolute ethanol to obtain the stock solution of
50 mg/ml and then diluted to the desired concen-
tration with the isotonic saline. Vioxx (Merck Sharp
& Dohme) was first dissolved in methanol to obtain
the stock solution 50 mg/ml and then diluted to
the desired concentration with isotonic saline as
described previously [23]. Resveratrol and Vioxx
were used in a dose (10 mg/kg and 5 mg/kg i.g., re-
spectively) that were shown by our group to inhibit
the PGE2 generation in the gastric mucosa injured
by I/R [23]. Control rats received the corresponding
vehicle. Our preliminary studies (data not shown)
confirmed that none of the cyclooxygenase inhibi-
tors used in this study produced by itself any gastric
lesions at the doses tested.
In another group of animals subjected to standard
ischemic preconditioning and then to I/R with or
without treatment with COX-1 and COX-2 inhibi-
tors, the prostaglandin deficit were replaced using
16,16 dimethyl prostaglandin E2 (Upjohn, Kalama-
zoo, MI, USA) applied in a dose of 1 mg/kg (i.g.)
that was found in our preliminary study to be wi-
thout any influence on gastric lesions caused by
I/R and accompanying fall in gastric blood flow (da-
ta not shown). For this purpose, 16,16 dimethyl
prostaglandin E2 analog was administered together
with each COX-1 or COX-2 inhibitor starting 30
min prior to standard ischemic preconditioning fol-
lowed by 3 h of I/R.
The area of gastric lesions was determined using
a planimeter (Morphomat, Carl Zeiss, Berlin, Ger-
many) under blinded conditions according to the
method described previously [26].
Involvement of NO in the protective effect 
of gastric preconditioning
The implication of NO in the effect of gastric pre-
conditioning on damage induced by I/R was deter-
mined by three ways; 1) by the using NG-nitro-L-
-arginine (L-NNA) applied i.g. in a dose of 20
mg/kg to suppress non-specifically the activity of
NOS [27]; 2) by the indirect measurement of NOS
product i.e. NO in gastric lumen [28]; and 3) by
addition to L-NNA of L-arginine, a substrate for
NOS or D-arginine, which is not a substrate for NO
[29]. The rats with gastric lesions induced by regu-
lar I/R were pretreated either with: 1) sham opera-
tion or standard ischemic preconditioning (occlu-
sion of celiac artery twice for 5 min) alone; 2) L-
-NNA (20 mg/kg i.g.) with or without the precondi-
tioning; 3) L-arginine (200 mg/kg i.g.) plus L-NNA
(20 mg/kg i.g.) combined with the preconditioning,
and finally; 4) D-arginine (200 mg/kg i.g.) plus L-
-NNA (20 mg/kg i.g.) combined with the precondi-
tioning.
The luminal concentration of NO was quantified in-
directly as nitrate (NO3
—) and nitrite (NO2
—) levels in
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the gastric contents using the nitrate/nitrite kit pur-
chased from Cayman Lab, Michigan, USA as descri-
bed in details before [29]. This method is based on
the Griess reaction and generation of chromophore
absorbing at 595 nm, according to the original pro-
cedure reported previously [30]. Since NO released
by epithelial cells into the gastric lumen is quickly
transformed into NO3
— and NO2
— [28], we measured
photometrically the sum of both these products of
NOS as an index of production of NO by the enzy-
me in the gastric mucosa. For this purpose, the ga-
stric content was aspirated just before the removal
of the stomach following the i.g. injection of 1 ml of
saline to wash out the luminal content. After centri-
fugation for 10 min at 3000 rpm, the samples were
mixed with Griess reagent from the commercially
available kit. In all tests including gastric preconditio-
ning with or without the combination with L-NNA
and L-arginine or D-arginine, the GBF was measu-
red in the oxyntic mucosa in each group of animals
in similar manner as mentioned before and expres-
sed as the percent control value recorded in vehicle-
-treated gastric mucosa.
Implication of adenosine in ischemic gastric 
preconditioning
The involvement of adenosine in the mediating of
the effect of preconditioning on the gastric mucosa
was determined by two ways: 1) by pretreatment
with 8-p-sulphophenyl theophylline (SPT) at a dose
(10 mg/kg i.g.), that was reported to inhibit adeno-
sine receptors and to attenuate the effect of ische-
mic preconditioning on the heart infarct size [31],
and 2) by the application of exogenous adenosine
(10 mg/kg i.g.) to check whether pretreatment with
exogenous adenosine can protect the gastric mu-
cosa lesions induced by regular I/R.
Measurement of gastric blood flow (GBF)
At the termination of each experiment, the gastric
blood flow (GBF) was measured by H2-gas clearance
technique. Rats were lightly anesthetized with ether,
the abdomen was opened and the stomach was
exposed. The gastric blood flow was measured in
the oxyntic gland area of the stomach by means of
local H2-gas clearance method using an electrolytic
regional blood flow meter (Biomedical Science, Mo-
del RBF-2, Japan) as described previously [23]. The
measurements were calculated in three areas of the
mucosa and the mean absolute values (ml/100 g-
-min) of these measurements were calculated and
expressed as percent changes from those recorded
in control animals treated with vehicle.
Determination of mucosal generation of PGE2
In groups of rats exposed to standard ischemic pre-
conditioning followed by regular I/R without or with
pretreatment with COX-inhibitors, the mucosal
samples form the oxyntic gland area were taken by
biopsy (about 200 mg) from gastric mucosa without
mucosal lesions immediately after the animals were
sacrificed to determine the mucosal generation of
PGE2 by radioimmunoassay (RIA) as described pre-
viously [25]. The mucosal samples were placed in
preweighed Eppendorf vial and 1 ml of Tris buffer
(50 mM, pH 9.5) was added to each vial. The sam-
ples were finely minced (during 15 s) with scissors,
washed and centrifuged for 10 s, the pellet being
resuspended again in 1 ml of Tris. Then, each sam-
ple was incubated on a Vortex mixer for 1 min and
centrifuged for 15 s. The pellet was weighed and
the supernatant was transferred to a second Eppen-
dorf vial containing indomethacin (10 mM) and
kept at —20¡C until the RIA. The capability of the
mucosa to generate PGE2 was expressed in nano-
grams of wet tissue weight.
Expression of COX-1 and COX-2 mRNA 
transcripts in the gastric mucosa determined 
by RT-PCR
COX-1 and COX-2 mRNA were determined by
RT-PCR in the gastric mucosa of intact rats or those
exposed to I/R with or without ischemia precondi-
tioning. Samples of the gastric oxyntic mucosa
(about 500 mg) were scraped off on ice using glass
slide and then immediately snap frozen in liquid
nitrogen, and stored at —80¡C. Total RNA was iso-
lated from the gastric oxyntic mucosa according to
Chomczynski and Sacchi [32] using a rapid guani-
dinum isothiocyanate/phenol chloroform single
step extraction kit from Stratagene (Stratagene
GmbH, Heidelberg, Germany).
First strand cDNA was synthesized from total cellular
RNA (5 mg) using 200 U Strata Script TM reverse
transcriptase and oligo (dt) primers (Stratagene
GmbH, Heidelberg, Germany). The primers for COX-
-1 and COX-2 were synthesized by Biometra (Gottin-
gen, Germany). The primer sequences were designed
according to the published cDNA sequence for the
rat b-actin and cyclooxygenases [33-36]. The COX-1
primer sequences were as follows: up-stream, 5Õ-AGC
CCC TCA TTC ACC CAT CAT TT; downstream, 5Õ-
-CAG GGA CGC CTG TTC TAC GG. The expected
length of this PCR product was 561 bp. The COX-2
primer sequences were as follows: upstream, 5Õ-ACA
ACA TTC CTT CCT TC; downstream, 5Õ-CCT TAT
TTC CTT TCA CAC C. The expected length of this
PCR product was 201 bp. Concomitantly, amplifica-
tion of control rat b-actin was performed on the same
samples to verify the RNA integrity. DNA amplifica-
tion was carried out under the following conditions;
denaturation at 94¡C for 1 min, annealing at 60¡C for
45 s and extension at 72¡C for 45 s. Each PCR-pro-
duct (8 ml) was electrophoresed on 1.5% agarose gel
stained with ethidium bromide, and then visualized
under UV light. Location of predicted PCR product
was confirmed by using a 100-base pair ladder (Gib-
co BRL/Life Technologies, Eggenstein, Germany) as
standard marker.
Statistical analysis
Results are expressed as means–SEM. The signifi-
cance of the difference between means was evalu-
ated using analysis of variance followed by Dun-
can‘s test with a level of confidence at P<0.05.
RESULTS
Effect of short ischemic episodes on the gastric le-
sions induced by I/R insult and the accompanying
changes in the GBF
Figure 1 shows the effects of various time duration
lasting from 37 s up to 300 s of single short ische-
mic episode on gastric lesions and accompanying
changes in the gastric blood flow induced by regu-
lar I/R. Ischemic episodes shorter than 75 s failed
to influence significantly the area of I/R-induced
gastric lesions and to affect the gastric blood flow.
With prolongation of ischemic episodes up to 150
s or 300 s applied before regular I/R a significant
reduction in the area of acute gastric lesions and
a significant rise of the gastric blood flow were ob-
served. The short ischemic of 5 min (300 s) that
caused reduction of I/R lesions by about 80% was
considered as a standard ischemic preconditioning
and used in subsequent studies.
Figure 2 shows the effect of various numbers of
standard (5 min) ischemic episodes ranging from 1
to 5 on the area of gastric erosions induced by re-
gular I/R. Single standard (5 min) preconditioning
episode reduced the area of I/R erosions by about
67%. Increase in number of standard ischemic epi-
sodes to two (2 ´ 5 min occlusion) did not result in
any further significant reduction in lesion area cau-
sed by regular I/R. The GBF in the intact stomach
averaged 53–6 (taken as 100%) and this was signi-
ficantly reduced (by about 40%) at the end of 3
h of reperfusion that followed 30 min of ischemia.
A single standard ischemic episode increased signi-
ficantly the GBF by about 25% as compared to that
recorded in sham-operated controls exposed to re-
gular I/R. Exposure of the gastric mucosa to 2—5
ischemic episodes produced similar rise in the ga-
stric blood flow but this increase was not significan-
tly different than that obtained in animals with sin-
gle ischemic episode.
Figure 3 shows the duration of the protective effect
of standard (2 ´ 5 min) ischemic preconditioning
against regular I/R. This protection followed by the
rise in the gastric blood flow was observed starting
from 2 h after the beginning of ischemic precondi-
tioning and found to last up to 8 h but after 12
h since the preconditioning such a protective effect
and accompanying hyperemia were lost and the
area of gastric lesions reached the value not signifi-
cantly different from that recorded in rats exposed
to regular I/R.
As shown in Figure 4, the pretreatment with stan-
dard preconditioning resulted in a significant atte-
nuation of gastric lesions induced by regular
I/R and in accompanying rise in the GBF similar to
that presented in Figure 2. This gastroprotection
and the rise in the GBF achieved by a standard
preconditioning against gastric lesions evoked by
regular I/R were not significantly different from tho-
se obtained in animals pretreated with mild irri-
tants such as 20% ethanol, 5% NaCl and 5 mM
taurocholate against mucosal damage induced by
100% ethanol, 25% NaCl and 80 mM taurochola-
te, respectively.
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Figure 1. Mean area of gastric lesions and the gastric blood flow
(GBF) in the gastric mucosa of rats pretreated with sham
(control) or ischemic preconditioning (IP) lasting from 37 up
to 300 s and then exposed to 30 min of ischemia followed
by 3 h of reperfusion. Results are mean–SEM of 6—8 rats.
Asterisk indicates a significant change as compared with the
value obtained in sham-control animals.
Figure 5 shows that standard preconditioning ap-
plied 30 min before regular I/R, 100% ethanol,
25% NaCl or 80 mM taurocholate attenuated signi-
ficantly the gastric lesions induced by each of these
strong irritants applied alone. Standard precondi-
tioning applied 30 min before i.g. application of
100% ethanol, 25% NaCl or 80 mM taurocholate
resulted in the significant attenuation of the lesion
area and in the rise in GBF as compared to those
recorded in sham-operated controls exposed 30
min later to 100% ethanol, 25% NaCl or 80 mM
taurocholate (Figure 5). The GBF in preconditioned
gastric mucosa followed by intragastric application
of necrotizing agents raised to similar extent to tho-
se treated with this preconditioning and exposed
to regular I/R.
Effect of non-selective and selective inhibitors of
COX-1 and COX-2 on the protection induced by
gastric preconditioning and the changes in the
GBF and PGE2 generation in the gastric mucosa
As shown in Figure 6, standard (2 ´ 5 min) precon-
ditioning attenuated the I/R-induced gastric lesions
and raised the GBF to the extent similar as presen-
ted in Figs. 2 and 3. Indomethacin, Vioxx and re-
sveratrol by themselves failed to influence signifi-
cantly the lesions and accompanying fall in the
GBF induced by I/R. In rats pretreated with indo-
methacin and then exposed to standard precondi-
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Figure 2. Effect of various numbers of 5 min ischemic episodes on the
area of acute gastric lesions and GBF in the gastric mucosa
of rats exposed to regular ischemia/reperfusion. Results are
mean–SEM of 6—8 rats. Asterisk indicates a significant
change as compared with the value obtained in sham-control
animals.
Figure 3. Effect of standard ischemic preconditioning followed 2 h, 4
h, 6 h, 8 h and 12 h later by regular ischemia/reperfusion on
the area of gastric lesions and GBF. Results are mean–SEM
of 6—8 rats. Asterisk indicates a significant change as
compared with the value obtained in sham-operated control
rats.
Figure 5. Effect of the pretreatment with standard IP on the area of
gastric lesions and accompanying changes in the GBF
induced by the exposure to regular I/R, 100% ethanol, 25%
NaCl and 80 mM TC. Results are mean–SEM of 6—8 rats.
Asterisk indicates a significant change as compared with the
value obtained in gastric mucosa without IP.
Figure 4. Effect of regular ischemia/reperfusion (I/R), 100% ethanol,
25% NaCl and 80 mM taurocholate (TC) applied alone or
pretreated with standard ischemic preconditioning (IP), 20%
ethanol, 5% NaCl and 5 mM TC on the area of gastric lesions
and accompanying changes in the GBF. Results are
mean–SEM of 6—8 rats. Asterisk indicates a significant
change as compared with the value obtained in gastric
mucosa without IP.
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tioning, the area of erosions caused by regular
I/R increased significantly above that recorded in
those with vehicle pretreatment and this effect was
accompanied by the significant fall in the GBF as
compared to the respective value obtained in pre-
conditioned rats. Pretreatment with Vioxx, a speci-
fic inhibitor of COX-2 or resveratrol, a specific inhi-
bitor of COX-1, also resulted in a significant incre-
ase in the area of gastric lesions accompanied by
a marked fall in the GBF but these alterations were
significantly smaller than those attained with indo-
methacin (Figure 6).
The generation of PGE2 in the intact gastric mu-
cosa averaged 128–12 ng/g of wet tissue weight
(Table 1). The exposure of gastric mucosa to re-
gular I/R that caused gastric lesions produced
a significant decrease (about 50%) in the PGE2
generation as compared to the values recorded
in the intact gastric mucosa (68–8 ng/g vs
128–12 ng/g of wet tissue weight, Table 1). The
administration of indomethacin (5 mg/kg i.p.)
that suppressed mucosal generation of PGE2 by
about 90% increased significantly the mean area
of I/R lesions and this effect was accompanied by
a significant fall in the GBF (Figure 6, Table 1).
Vioxx failed to affect significantly the generation
of PGE2 in the gastric mucosa not exposed to I/R.
When Vioxx was applied i.g. in a dose of 5
mg/kg, the significant increase in gastric lesions
and the fall in the GBF and PGE2 were observed.
Resveratrol, which also augmented significantly
the area of gastric lesions induced by I/R produ-
ced a significant fall in the PGE2 generation (Ta-
ble 1).
As shown in Figure 6, the area gastric lesions me-
asured after I/R preceded by standard preconditio-
ning was significantly higher and the GBF was si-
gnificantly lower in this series of experiments in rats
pretreated with indomethacin (5 mg/kg i.p.), Vioxx
(5 mg/kg i.g.) and resveratrol (10 mg/kg i.g.) ap-
plied 30 min before short ischemia as compared to
that recorded in vehicle-treated animals. Addition
of PGE2 (1 mg/kg i.g.), which by itself failed to influ-
ence significantly the I/R lesions (data not shown),
attenuated significantly the enhancement in area of
these lesions and accompanying fall in GBF indu-
ced by indomethacin (Figure 6). PGE2 added to
Vioxx or resveratrol abolished completely the in-
crease in area of gastric lesions and accompanying
fall in the GBF induced by administration of these
COX-inhibitors (Figure 6).
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Resveratrol + IP
128 –12
154 – 10*
33 – 4*
118 – 13
104 – 9*
68 – 8*
118 – 6+
18 – 3++
64 –5++
55 – 4++
Table 1. Effect of standard ischemic preconditioning (IP) without or
with the pretreatment with resveratrol (10 mg/kg i.g), Vioxx (5
mg/kg i.g.) and indomethacin (5 mg/kg i.p.), on the mucosal
generation of PGE2 in gastric mucosa exposed to regular
ischemia/reperfusion. Results are mean – SEM of 8-10 rats.
Asterisk indicates a significant change as compared to the
value obtained in intact gastric mucosa. Cross indicates a
significant change as compared to the value obtained in
gastric mucosa exposed to ischemia-reperfusion.  Double
cross indicates a significant change as compared to the
respective value obtained in gastric mucosa not exposed to
Figure 6. Effect of standard IP with or without pretreatment with
indomethacin (5 mg/kg i.p.), Vioxx (5 mg/kg i.g.) and
resveratrol (10 mg/kg i.g.) administered with or without
addition of 16, 16 dm prostaglandin E2 (PGE2 1 mg/kg i.g.)
on the area of gastric lesions and accompanying changes in
the GBF induced by the exposure to regular I/R. Results are
mean–SEM of 6—8 rats. Asterisk indicates a significant
change as compared with the value obtained in sham-control
gastric mucosa. Cross indicates a significant change as
compared with the value obtained in rats without treatment
with COX inhibitors. Double cross indicates a significant
change as compared to the value obtained in rats without
PGE2 administration.
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Effect of L-NNA on gastric lesions, gastric blood
flow and NO production in gastric mucosa expo-
sed to I/R with or without gastric preconditioning
Figure 7 shows the results of tests with standard
preconditioning with or without addition of L-
-NNA or the combination of L-NNA plus L-argini-
ne or D-arginine on the area of gastric luminal
contents of NO3
— /NO2
— and the GBF. The pretre-
atment with short ischemia resulted in usual atte-
nuation of lesion area and an increase in the GBF
and produced a significant rise in luminal con-
tents NO3
— /NO2
—. L-NNA applied i.g. in a dose of
20 mg/kg, aggravated significantly the lesions in-
duced I/R and decreased the GBF and luminal
release of NO degradation products as compared
to those in vehicle-treated animals. Such treat-
ment with L-NNA abolished the decrease in
I/R lesions, the rise in the GBF and the produc-
tion of NO into gastric lumen recorded in ani-
mals subjected to gastric preconditioning applied
before I/R (Figure 7). Addition of L-arginine but
not D-arginine to the combination of L-NNA and
short ischemic restored the protective effect, the
rise in GBF and luminal NO3
— /NO2
— content to the
levels observed in rats pretreated with short
ischemic (Figure 7).
Effect of exogenous adenosine and suppression of
adenosine receptors by 8-phenyl theophylline on
the gastric lesions induced by I/R with or without
short ischemic
Pretreatment with adenosine (10 mg/kg i.g.) atte-
nuated significantly the lesions induced by regular
I/R and increased the GBF with the extent similar
to that observed with standard preconditioning (Fi-
gure 8). An non-selective antagonist of adenosine
receptors, 8-p-sulphophenyl theophylline (SPT, 10
mg/kg i.g.), which by itself failed to influence the
area of gastric lesions and accompanying increase
in the GBF, reduced significantly the protection
and rise in the GBF caused by both, gastric precon-
ditioning or pretreatment with exogenous adenosi-
ne against lesions induced by I/R (Figure 8).
Expression of COX-1 and COX-2 mRNA by RT-
-PCR in gastric mucosa exposed to I/R lesions
with or without standard preconditioning
Figure 9 (right panel) shows expression of b-actin,
COX-1 and COX-2 mRNA in the gastric mucosa of
intact rats treated with vehicle and not exposed to
regular I/R or those exposed to I/R with or without
standard ischemic preconditioning and killed im-
mediately after the end of regular I/R. The expres-
sion of b-actin mRNA was well-preserved in the
mucosal samples taken both from rats treated with
vehicle (control) or exposed to I/R and tested at va-
rious time intervals (Figure 9). The COX-1 mRNA
was detectable in the vehicle-treated gastric muco-
sa as well as in the mucosa exposed to regular
I/R at all time intervals after the end of I/R. Ratio
mRNA COX-1 over b-actin revealed that the
expression of COX-1 mRNA was similar in gastric
mucosa exposed to I/R with or without I/R (Figure
9, left panel). In contrast, the signal for COX-2
mRNA was not detected in vehicle control animals
but has been traced in rats exposed to I/R and in
those treated with short ischaemia prior to exposu-
re to I/R (Figure 9, right panel). The ratio of COX-2
mRNA over b-actin mRNA showed the expression
of COX-2 in preconditioned mucosa was signifi-
cantly higher than that recorded in animals imme-
diately after the end of I/R without gastric precon-
ditioning (Figure 9, left panel).
DISCUSSION
This study demonstrates that preconditioning of
the gastric mucosa with short episodes of ischemia
in the stomach exerts significant protection against
+ L-NNA   (20 mg/kg i.p.)
+ IP
Sham Sham Sham L-Arg D-ArgIP
G
B
F 
(%
 c
on
tr
ol
)
Lu
m
in
al
 N
O
 (
µM
/L
)
* *
*
*
++
++
++
0
10
20
30
40
50
0
20
40
60
80
100
5
10
15
20
25
30
+
+ +
+
+
+
Ischemia/Reperfusion
M
ea
n 
le
si
on
 a
re
a 
(m
m
2 )
Figure 7. Effect of standard IP with or without pretreatment with NG-
nitro-L-arginine (L-NNA 20 mg/kg i.p.) applied with or
without the combination with L-arginine (L-Arg, 200 mg/kg
i.g.) or D-arginine (D-Arg, 200 mg/kg i.g.) on the area of
gastric lesions and accompanying changes in the GBF and
gastric luminal NO concentration induced by the exposure to
regular I/R. Results are mean–SEM of 6—8 rats. Asterisk
indicates a significant change as compared with the value
obtained in sham-control gastric mucosa. Cross indicates a
significant change as compared with the value obtained in
rats without treatment with L-NNA. Double cross indicates a
significant change as compared to the value obtained in rats
without L-Arg administration.
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lesions caused by longer exposure to regular
I/R (I/R) and this protective effect depends upon
the time of ischemic episodes. To our best know-
ledge, this is the first demonstration that pheno-
menon of preconditioning described originally in
various organs including heart, lungs, liver and in-
testine [1—6,9,10], occurs also in the stomach re-
sulting in the limitation of the mucosal damage
evoked by the I/R. Our study indicates that gastric
preconditioning may represent one of the most
powerful protective intervention against the dama-
ge induced by severe I/R as well as various necro-
tizing substances including 100 % ethanol in the
stomach.
Based on our results, it is reasonable to assume
that gastric preconditioning involves several media-
tors including prostaglandin derived from COX-1
and COX-2 activity, NO and adenosine that appe-
ar to play a key role in the mechanism of this pro-
tection probably by causing vasodilatation and en-
hancement the GBF. This notion is supported by
the fact that protection and accompanying rise in
the GBF induced by gastric preconditioning were
significantly attenuated by inhibition of COX-1 and
COX-2 and by L-NNA suppressing NO-synthase
activity. The involvement of the above mediators is
supported by the effect of concurrent treatment
with synthetic PGE2 to compensate for the defi-
ciency of endogenous prostaglandin and by L-argi-
nine to provide a substrate for NO synthase. Fur-
thermore, we found that the protective and hype-
remic effects of preconditioning against I/R were
antagonized by SPT, an antagonist of adenosine re-
ceptors and that exogenous adenosine attenuated
significantly gastric lesions induced by I/R with the
extent similar to that observed after standard ische-
mic preconditioning suggesting that adenosine may
be the major factor contributing to the beneficial
effect of gastric preconditioning in the stomach.
Previous studies demonstrated that prostaglandins
applied exogenously or generated endogenously in
the gastric mucosa, exhibit high activity in preven-
ting the mucosal damage induced by necrotizing
substances including boiling water [13,14]. Adapti-
ve cytoprotection was introduced originally by Ro-
bert and his associates [13] to describe the protec-
tive activity of endogenous prostaglandin genera-
ted within gastric mucosa by mild topical irritants
such as 20% ethanol or 5% NaCl to against severe
mucosal damage induced by strong irritants such as
100% ethanol or 25% NaCl. We demonstrated
previously [14] that mild irritants offer the cross-
-protective response, e.g. 5% NaCl was effective in
attenuation of damage induced not only by necro-
tizing 25% NaCl but also by 100% ethanol, while
20% ethanol prevented the damage caused by
25% NaCl.
Besides prostaglandin also NO was later on impli-
cated as mediator of this adaptation [15—17] and in
fact some reports suggested that prostaglandin may
not be primary mediators of this mucosal adaptive
protection [37]. It is of interest that this protective
mucosal mild-irritation was proposed to act locally
because mild irritants failed to exhibit any protecti-
ve activity when applied systemically [14].
Preconditioning refers to a phenomenon in which
a tissue is rendered resistant to the deleterious ef-
fects of severe and prolonged ischemia followed by
reperfusion by previous exposures to brief periods
of vascular occlusion [4]. While the beneficial ef-
fects of preconditioning were first demonstrated in
the myocardium [2], it is now evident that this pre-
conditioning protects against postischemic damage
of brain, kidney, skeletal muscle and gastrointesti-
nal organs including small bowel and liver
[1—3,6,11,12]. Mechanism of protection induced
by preconditioning has not been fully explained
but activation of adenosine A1 receptors and ATP-
-sensitive potassium channels in the heart as well
as an inhibition of neutrophil activation and emi-
gration in the intestine were implicated in this phe-
nomenon [4]. No attempts were made however, to
examine whether preconditioning in the stomach
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Figure 8. Effect of standard IP and adenosine (10 mg/kg i.g.) applied
alone or combined with 8-p-sulphophenyl theophylline (SPT;
10 mg/kg i.p.) on gastric lesions and accompanying
changes in the GBF induced by the exposure to regular I/R.
Results are mean–SEM of 6—8 rats. Asterisk indicates a
significant change as compared with the value obtained in
sham-control gastric mucosa. Cross indicates a significant
change as compared with the value obtained in rats without
treatment with SPT.
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could enhance its mucosal resistance against the
damage induced by subsequent exposure to pro-
longed and severe I/R.
In present study we compared the effect of pre-
conditioning on the gastric mucosa injured by
I/R with that exhibited by mild irritants. We confir-
med that gastric mucosa pretreated with mild irri-
tants such as 5% NaCl, 20% ethanol or 5 mM tau-
rocholate, acquires a tolerance against subsequent
damaging insults of strong irritants such as 25%
NaCl, 100% ethanol of 80 mM taurocholate and
we found for the first time that this increased tole-
rance was also achieved by gastric preconditioning.
Furthermore, we have demonstrated for the first ti-
me that the preconditioning protected gastric mu-
cosa also against lesions induced by strong irritants
such as 100% ethanol, 25% NaCl and 80 mM tau-
rocholate indicating that the preconditioning like
mild irritants [13,14] affords cross-protection aga-
inst lesions caused by these strong irritants.
We attempted in this study to determine the possi-
ble mechanism of gastric preconditioning and the
role of endogenous prostaglandin, NO and adeno-
sine as potential mediators of this protection in the
stomach. Numerous studies have documented that
prostaglandin derived from the activity of the COX
isoforms, especially COX-1, play an important role
in mechanism of gastric integrity, gastroprotection
[13,14] and ulcer healing [26]. Recently prostaglan-
din-derived from cyclooxygenase-2 were implicated
in the protective and ulcer healing activities of
growth factors by the demonstration that COX-2 is
upregulated in the edge of gastric ulcer and that this
is significantly enhanced by the treatment with
growth factors [38]. Moreover, endogenous prosta-
glandin derived from COX-1 and COX-2 are invo-
lved in the mechanism of mucosal recovery from
I/R-induced acute gastric erosions that subsequently
progressed into deeper ulcerations and that healing
of these ulcers is associated with an overexpression
of COX-2 mRNA [23]. The involvement of these
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Figure 9. Messenger RNA expression for b-actin, cyclooxygenase (COX)-1 and cyclooxygenase (COX)-2 mRNA (right panel) and assessment of
mucosal gene expression for COX-1 and COX-2 by the intensity of COX-1, COX-2 mRNA/b-actin mRNA ratio in intact gastric mucosa (lane
1), sham plus regular I/R (lane 2), standard IP plus regular I/R (lane 3) and IP alone (lane 4). M — size marker DNA, Arrow — expected PCR
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arachidonate products in the mechanism of precon-
ditioning has not been fully elucidated but it was
suggested that in the heart certain prostaglandin
such as prostacyclin, that is released from ischemic
myocardium, may limit the extent of heart infarct
and attenuate ventricular arrhythmia and that inhi-
bition of COX prevented the protective effect of
ischemic preconditioning in dog myocardium [1,2].
Our results with the preconditioning in the stomach
are in keeping with these findings by showing direc-
tly that COX-2 is overexpressed in the preconditio-
ned gastric mucosa, at the levels of both, mRNA
and protein, while COX-1 mRNA remains unchan-
ged. Moreover, the suppression of the PG biosyn-
thesis by non-selective (indomethacin) and selective
COX-1 (resveratrol) or COX-2 (Vioxx) inhibitors at-
tenuated or abolished the protective and hypere-
mic effects of gastric preconditioning. Furthermore
minute amounts of synthetic PGE2 analog added to
these COX inhibitors restored the protection by
preconditioning reinforcing the notion that endoge-
nous PG produced in excessive amounts by COX-2,
play an important role in the mechanism of gastric
preconditioning.
Previous studies revealed that NO released from
vascular endothelium, sensory afferent nerves or
gastric epithelium is essential for the gastroprotec-
tion and ulcer healing [27—30,39,40]. We docu-
mented previously that administration of NO-syn-
thase inhibitors abolished the gastroprotective acti-
vity of capsaicin in the stomach and delayed he-
aling of chronic gastric ulcers [40]. Our present
study implies that NO could also participate as
a candidate mediator in gastric preconditioning.
In agreement to previous findings that NO derived
from L-arginine metabolic pathway could contri-
bute to the mechanism of preconditioning in the
liver injury induced by hepatic I/R [5,41] we found
that the gastroprotection afforded by gastric pre-
conditioning is accompanied by the rise in the ga-
stric blood flow probably due to enhanced pro-
duction of NO in the gastric mucosa. Both these
effects occurring after preconditioning were com-
pletely abolished in rats with suppressed NO syn-
thase activity by L-NNA. The important role of NO
is further supported by the finding that addition to
L-NNA of L-arginine, the substrate for NOS activi-
ty, but not D-arginine, restored the gastroprotec-
tion against I/R, luminal release of NO and the hy-
peremia evoked by gastric preconditioning.
We also tested the hypothesis, suggested by others
in hepatic preconditioning [6], that adenosine plays
a crucial role in the mechanism of gastric precondi-
tioning. Indeed, the beneficial effects of precondi-
tioning were blocked, at least in part by the admi-
nistration of non-selective adenosine receptor an-
tagonist SPT. Furthermore the pretreatment with
adenosine in non-preconditioned animals resem-
bled the protective effect of preconditioning aga-
inst the I/R gastric injury. These observations are
consistent with the hypothesis that locally released
adenosine during preconditioning could trigger the
preconditioning phenomenon via activation of
adenosine receptors.
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